Lv4
660 积分 2024-11-25 加入
Immunological features of EGFR-mutant non-small cell lung cancer and clinical practice: a narrative review
5小时前
待确认
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
11天前
已完结
Longitudinal Analyses of Circulating Tumor DNA for the Detection of EGFR Mutation-Positive Advanced NSCLC Progression During Treatment: Data From FLAURA and AURA3
3个月前
已完结
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
3个月前
已完结
PL02.07 IMpower 133: Primary PFS, OS and Safety in a PH1/3 Study of 1L Atezolizumab + Carboplatin + Etoposide in Extensive-Stage SCLC
3个月前
已完结
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort
3个月前
已完结
Hallmarks of Cancer: The Next Generation
3个月前
已完结
Use of immune checkpoint inhibitors in patients with lung cancer and multiple sclerosis
3个月前
已关闭
PD‐1/PD‐L1 immune checkpoint: Potential target for cancer therapy
3个月前
已完结
Small-cell lung cancer detection in never-smokers: clinical characteristics and multigene mutation profiling using targeted next-generation sequencing
3个月前
已完结
皖公网安备34019202002308
